Publications

Glover C, Deng L, Larter C, Brogan C, Richardson O, Huang YA, Kay E, Macartney K, Wood N. Surveillance of adverse events following immunisation in Australia annual report, 2021. Communicable Diseases Intelligence (2018) 2024;48. doi: 10.33321/cdi.2024.48.1. [Full text]

Imai C, Jayasinghe S, McRae J, Li-Kim-Moy J, Chiu C, Macartney K, Burns P, Cooper K, Cheng AC, Gibney K, Giles M, Jones C, Korman T, Liu B, Crawford NW; Australian Technical Advisory Group on Immunisation (ATAGI). Surveillance of adverse events following immunisation in Australia annual report, 2021.. Communicable Diseases Intelligence (2018) 2024;48. doi: 10.33321/cdi.2024.48.25. [Full text]

Kandasamy R, Gurung M, Shrestha S, Gautam MC, Kelly S, Thorson S, Ansari I, Gould K, Hinds J, Kelly DF, Murdoch DR, Pollard AJ, Shrestha S. Decline in pneumococcal vaccine serotype carriage, multiple-serotype carriage, and carriage density in Nepalese children after PCV10 introduction: a pre-post comparison study. Vaccine 2024:S0264-410X(24)00564-4. doi: 10.1016/j.vaccine.2024.05.018 . [Full text]

Marsland MJ, Thomson TN, O'Brien HM, Peach E, Bellette J, Humphreys N, McKeon CA, Cross W, Moso MA, Batty M, Nicholson S, Karapanagiotidis T, Lim CK, Williamson DA, Winkler N, Koirala A, Macartney K, Glynn-Robinson A, Stewart T, Minko C, Snow KJ, Black J, Friedman ND. Serosurvey for Japanese encephalitis virus antibodies following an outbreak in an immunologically naïve population, Victoria, 2022: a cross-sectional study. Medical Journal of Australia 2024. doi: 10.5694/mja2.52344 . [Full text]

Baldwin Z, Hueston L, Roberts-Witteveen A, Stanley P, Sheel M, Winkler N, Koirala A, Macartney K, Case J, Hope K, Glasgow KM. The seroprevalence of antibodies to Japanese encephalitis virus in five New South Wales towns at high risk of infection, 2022: a cross-sectional serosurvey. Medical Journal of Australia 2024. doi: 10.5694/mja2.52320 . [Full text]

Muttucumaru R, Lau CL, Leeb A, Mills DJ, Wood N, Furuya-Kanamori L. Post-marketing surveillance of 10,392 herpes zoster vaccines doses in Australia. Vaccine 2024;42:3166-3171. doi: 10.1016/j.vaccine.2024.03.066 . [Full text]

Townley B, Akin D, Dimaguila GL, Sawires R, Sepulveda Kattan G, King S, Bines J, Wood N, Lambert S, Buttery J. Exploring the infectious contribution to intussusception causality using the effects of COVID-19 lockdowns in Australia: an ecological study. Clinical Infectious Diseases 2024;79:255-262. doi: 10.1093/cid/ciae084. [Abstract]

Carter MJ, Shrestha S, O'Reilly P, Gurung P, Gurung M, Thorson S, Kandasamy R, Voysey M, O'Mahony E, Kelly S, Ansari I, Shah G, Amatya P, Tcherniaeva I, Berbers G, Murdoch DR, Pollard AJ, Shrestha S, Kelly DF; on behalf the PneumoNepal Study Group. Evaluation of acute and convalescent antibody concentration against pneumococcal capsular polysaccharides for the diagnosis of pneumococcal infection in children with community-acquired pneumonia. Pediatric Infectious Diseases Journal 2024;43:e67-e70. doi: 10.1097/INF.0000000000004185. [Full text]

Albutti A, Mahdi HA, Alwashmi AS, Alfelali M, Barasheed O, Barnes EH, Shaban RZ, Booy R, Rashid H. The relationship between hand hygiene and rates of acute respiratory infections among Umrah pilgrims: a pilot randomised controlled trial. Journal of Infection and Public Health 2024;17:34-41. doi: 10.1016/j.jiph.2023.04.003. [Full text]

Walker GJ, Foster CS, Sevendal A, Domazetovska A, Kamalakkannan A, Williams PC, Kim KW, Condylios A, Stelzer-Braid S, Bartlett AW, Rawlinson W. Clinical, genomic, and immunological characterization of RSV surge in Sydney, Australia, 2022. Pediatrics 2024;153:e2023063667. doi: 10.1542/peds.2023-063667. [Full text]